Laser trabeculoplasty suitable for all open-angle glaucoma patients
May 10th 2017Prostaglandin-based topical therapy has been the ‘go-to treatment’ for open-angle glaucoma for decades. In contrast, laser trabeculoplasty has conventionally remained reserved for patients unresponsive or unable to adhere to medication-based therapy.
ECP provides primary secondary therapy option for glaucoma
May 10th 2017For 20 years I have effectively employed endoscopic cyclophotocoagulation (ECP) as a primary or secondary line of glaucoma treatment. ECP is a minimally invasive glaucoma surgical (MIGS) option capable of reducing IOP in the majority of patients and can potentially eliminate the need for drainage surgery, including trabeculectomy (trab) and glaucoma drainage devices (GDDs).
Innovator in small pupil management recognized with Binkhorst Medal
May 6th 2017At the 2006 ASCRS Film Festival, Dr. Malyugin, professor of ophthalmology and deputy director, S. Fyodorov Eye Microsurgery Institution, Moscow, received the first-place award in the instruments/devices category for his video, “Russian solution to small-pupil phaco and tamsulosin floppy-iris syndrome,” that presented the pupil expansion ring he designed for atraumatic management of the small pupil.
Cirle unveils latest 3-D surgical navigation system
May 6th 2017Cirle Inc. announced the unveiling of its latest three-dimensional Surgical Navigation System (SNS 200) at the 2017 meeting of the American Society of Cataract and Refractive Surgery. The investigational system is completing FDA registration.
Multicenter study supports efficacy of novel gel stent in refractory glaucoma
May 6th 2017Ab interno placement of a novel gelatin stent (XEN 45, Allergan) in eyes with refractory glaucoma lowers IOP and medication use with a low incidence of complications and adverse events, according to results of a U.S. multicenter trial.
Premium IOLs in corneal disease an individualized decision
May 5th 2017Patients with concurrent corneal disease may be candidates for premium IOLs to correct presbyopia and/or astigmatism, but often these individuals need corneal surgery before or after the cataract procedure, said William B. Trattler, MD.
Considering laser cataract surgery in combined glaucoma procedures
May 5th 2017Femtosecond laser-assisted cataract surgery (FLACS) has some benefits for patients and for surgeons, but it remains to be seen if it adds value when used in combined glaucoma-cataract procedures, said Leon W. Herndon Jr., MD.
Ocular surface optimization key in refractive surgery management
May 5th 2017Dry eye disease (DED) is extremely common in the adult population and important to diagnose and treat in patients undergoing corneal and cataract refractive surgery because it can affect vision, quality of life, and surgical outcomes, said Edward J. Holland, MD.
The secret to reducing staff turnover
April 15th 2017Is staff turnover holding you back? In some markets, healthcare personnel turnover is five times higher than unemployment. The average total turnover rate reported for healthcare employers in 2016 is 20.1%, up from 19.2% in 2015, according to Compdata Surveys’ national survey, Compensation Data Healthcare.
Cataract, glaucoma surgery in uveitis patients present added challenges
April 15th 2017Cataract surgery in patients with coexisting uveitis is more challenging than managing either condition alone. Surgeons must answer a different set of questions and consider alternative management strategies, said Debra A. Goldstein, MD, FRSC, professor of ophthalmology and director of the Uveitis Service, Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago.
New IOL category offers more natural range of vision
April 14th 2017There are a number of ways to improve near vision for presbyopes, including multifocal intraocular lenses (IOLs)–traditional or low add–and pseudoaccommodative IOLs. It has been well documented that a small pupil and higher order aberrations, such as spherical aberration (SA) or coma, can increase depth of focus.
New paradigm shift in selecting a steroid course prior to FAc implant
April 8th 2017As retinal specialists, we are truly fortunate to live in a time where we have several treatment options for patients with diabetic macular edema (DME). A fluocinolone acetonide (FAc) intravitreal implant 0.19 mg (Iluvien, Alimera Sciences) is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in IOP.
Dr. William Tasman, former Wills Eye ophthalmologist-in-chief, dies
April 1st 2017Wills Eye Hospital’s “powerhouse” William Tasman, MD, passed away March 28, 2017, at the age of 87. In the same short period, the retinal world had another sad passing of Eliot L. Berson, MD, on March 19, 2017 at the age of 79.
Blocked clinic flow can be analogous to a beaver dam
April 1st 2017Meaningful use and government mandates have added blocks all throughout the system that continue to add more and more time to each patient visit--and ends up damming up the clinic from ever getting their hands on the patient to do the exam.
Does FLACS cost, benefit outweigh manual? Yes!
April 1st 2017Though further study is needed to determine conclusively whether or not femtosecond laser-assisted cataract surgery (FLACS) is associated with better refractive outcomes compared with conventional manual surgery, FLACS offers many other benefits that justify its use, according to Robert J. Cionni, MD.
Does FLACS cost, benefit outweigh manual? No!
April 1st 2017Femtosecond laser-assisted cataract surgery (FLACS) offers some advantages compared with a conventional manual procedure, particularly for certain patients. Currently, however, FLACS does not result in superior outcomes and it has drawbacks that outweigh its benefits, according to Rosa Braga-Mele, MD.